Literature DB >> 22752358

[Cytokines in psychoneuroendocrine immunological context of nonspecific musculoskeletal pain].

C Ahrens1, M Schiltenwolf, H Wang.   

Abstract

Cytokines are coordinators of immune homeostasis. Evidence for the participation of cytokines in neurogenic inflammation, peripheral and central sensitization and hyperalgesia as well as for induction of inflammatory immune responses by pain-related catastrophizing is well documented. A disproportion of proinflammatory and anti-inflammatory cytokines is known to be a contributory cause of pain and pain behavior. Embedded into psychoneuroendocrine immunological feedback control systems cytokines are able to perpetuate a virtuous circle between local inflammation and systemic pain behavior (pain/sickness behavior) thus contributing to chronification of nonspecific musculoskeletal pain.In this model avoidance and pain-related nonrecognition as key components of systemic pain behavior lead to maintenance of the virtuous circle by generating of a local inflammation with local and systemic consequences. This model can explain the success of established therapy concepts from the point of view of psychoneuroimmunology, such as fear avoidance, which are effectively used as principal components in multimodal pain therapy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22752358     DOI: 10.1007/s00482-012-1153-5

Source DB:  PubMed          Journal:  Schmerz        ISSN: 0932-433X            Impact factor:   1.107


  43 in total

Review 1.  Stress, chronic inflammation, and emotional and physical well-being: concurrent effects and chronic sequelae.

Authors:  G P Chrousos
Journal:  J Allergy Clin Immunol       Date:  2000-11       Impact factor: 10.793

2.  Pro- and anti-inflammatory cytokine gene expression in rat sciatic nerve chronic constriction injury model of neuropathic pain.

Authors:  K Okamoto; D P Martin; J D Schmelzer; Y Mitsui; P A Low
Journal:  Exp Neurol       Date:  2001-06       Impact factor: 5.330

3.  Reduced levels of antiinflammatory cytokines in patients with chronic widespread pain.

Authors:  Nurcan Uçeyler; Regine Valenza; Michael Stock; Robert Schedel; Günter Sprotte; Claudia Sommer
Journal:  Arthritis Rheum       Date:  2006-08

4.  Somatization--future perspectives on a common phenomenon.

Authors:  W Rief; W Hiller
Journal:  J Psychosom Res       Date:  1998-05       Impact factor: 3.006

5.  Interleukin-1beta induces substance P release from primary afferent neurons through the cyclooxygenase-2 system.

Authors:  A Inoue; K Ikoma; N Morioka; K Kumagai; T Hashimoto; I Hide; Y Nakata
Journal:  J Neurochem       Date:  1999-11       Impact factor: 5.372

6.  Toward a biochemical understanding of human intervertebral disc degeneration and herniation. Contributions of nitric oxide, interleukins, prostaglandin E2, and matrix metalloproteinases.

Authors:  J D Kang; M Stefanovic-Racic; L A McIntyre; H I Georgescu; C H Evans
Journal:  Spine (Phila Pa 1976)       Date:  1997-05-15       Impact factor: 3.468

7.  Cytokine involvement in dynorphin-induced allodynia.

Authors:  T M Laughlin; J R Bethea; R P Yezierski; G L Wilcox
Journal:  Pain       Date:  2000-02       Impact factor: 6.961

Review 8.  Neural-immune interactions: implications for pain management in patients with low-back pain and sciatica.

Authors:  Angela Starkweather; Linda Witek-Janusek; Herbert L Mathews
Journal:  Biol Res Nurs       Date:  2005-01       Impact factor: 2.522

9.  A functional anatomical analysis of central pathways subserving the effects of interleukin-1 on stress-related neuroendocrine neurons.

Authors:  A Ericsson; K J Kovács; P E Sawchenko
Journal:  J Neurosci       Date:  1994-02       Impact factor: 6.167

Review 10.  Recent findings on how proinflammatory cytokines cause pain: peripheral mechanisms in inflammatory and neuropathic hyperalgesia.

Authors:  Claudia Sommer; Michaela Kress
Journal:  Neurosci Lett       Date:  2004-05-06       Impact factor: 3.046

View more
  2 in total

1.  Serial whole-body cryotherapy in fibromyalgia is effective and alters cytokine profiles.

Authors:  Philipp Klemm; Johanna Becker; Iris Aykara; Thomas Asendorf; Gabriel Dischereit; Elena Neumann; Ulf Müller-Ladner; Uwe Lange
Journal:  Adv Rheumatol       Date:  2021-01-13

2.  Evidence of both systemic inflammation and neuroinflammation in fibromyalgia patients, as assessed by a multiplex protein panel applied to the cerebrospinal fluid and to plasma.

Authors:  Emmanuel Bäckryd; Lars Tanum; Anne-Li Lind; Anders Larsson; Torsten Gordh
Journal:  J Pain Res       Date:  2017-03-03       Impact factor: 3.133

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.